科研速览 · Science Skim继续刷下去 · Keep skimming →
◆ Neonatology2026-08-28

The First Reported Transcatheter Closure of Patent Ductus Venosus Using the LifeTech™ Konar-MFO VSD Occluder in an Infant with Hyperammonemia.

Hung-Yao Yun, Hsin-Wei Chou, Yi-Hsuan Su, Yu-Hsuan Chien

一句话结论 · In one sentence

This report describes the first global use of the Konar-MFO device for PDV closure. Transcatheter embolization using this device is a safe and effective minimally invasive treatment for symptomatic PDV in young infants.

原始摘要(英文原文)· Original abstract
INTRODUCTION: Congenital portosystemic shunts (CPSS) are rare vascular anomalies that can lead to hyperammonemia and liver dysfunction. CASE PRESENTATION: A 1-month-old infant was diagnosed with incidental patent ductus venosus (PDV) and a focal nodular hyperplasia-like liver nodule. Laboratory tests revealed hyperammonemia (192 µmol/L) and cholestasis. Imaging confirmed a 7.8-mm shunt connecting the left portal vein to the inferior vena cava. Urgent transcatheter closure was performed via the right jugular vein using a 12/10-mm LifeTech™ Konar-MFO occluder. Post-procedural imaging showed complete shunt occlusion, and ammonia levels rapidly decreased to 71.8 µmol/L. Cholestasis improved, and the patient was discharged without complications. CONCLUSION: This report describes the first global use of the Konar-MFO device for PDV closure. Transcatheter embolization using this device is a safe and effective minimally invasive treatment for symptomatic PDV in young infants.
读原文 · Read the paper ↗

AI 追问PRO

登录后使用 AI 追问

讨论区

登录后参与讨论

相关论文 · Related

The First Reported Transcatheter Closure of Patent Ductus Venosus Using the LifeTech™ Konar-MFO VSD Occluder in an Infant with Hyperammonemia. — 科研速览 Science Skim